LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (NASDAQ: CYTR) today announced that David J. Haen, Director of Business Development at CytRx, and Tod Woolf, Ph.D., President of CytRx’s majority-owned RNAi subsidiary RXi Pharmaceutical Corporation (RXi), are scheduled to present at the Acumen BioFin Rodman & Renshaw 4th Annual Global Healthcare Conference on Monday, May 14, at 12:55 p.m. local time (6:55 a.m. Eastern time). The conference is being held at the Le Meridien Beach Plaza Hotel in Monte Carlo, Monaco.
